These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38847725)

  • 21. LncRNA LINC00649 promotes the growth and metastasis of triple-negative breast cancer by maintaining the stability of HIF-1α through the NF90/NF45 complex.
    Zhang J; Du C; Zhang L; Wang Y; Zhang Y; Li J
    Cell Cycle; 2022 May; 21(10):1034-1047. PubMed ID: 35188449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIF
    Tang W; Long T; Li F; Peng C; Zhao S; Chen X; Su J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Apr; 46(4):333-344. PubMed ID: 33967078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Down-regulating HIF-1α by lentivirus-mediated shRNA for therapy of triple negative breast cancer.
    Li S; Wei Q; Li Q; Zhang B; Xiao Q
    Cancer Biol Ther; 2015; 16(6):866-75. PubMed ID: 25920936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CHCHD2 is a potential prognostic factor for NSCLC and is associated with HIF-1a expression.
    Yin X; Xia J; Sun Y; Zhang Z
    BMC Pulm Med; 2020 Feb; 20(1):40. PubMed ID: 32054470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression and significance of hypoxia inducible factor-1α and lysyl oxidase in non-small cell lung cancer.
    Ping W; Jiang WY; Chen WS; Sun W; Fu XN
    Asian Pac J Cancer Prev; 2013; 14(6):3613-8. PubMed ID: 23886154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FOXO3a expression is associated with lymph node metastasis and poor disease-free survival in triple-negative breast cancer.
    Rehman A; Kim Y; Kim H; Sim J; Ahn H; Chung MS; Shin SJ; Jang K
    J Clin Pathol; 2018 Sep; 71(9):806-813. PubMed ID: 29588373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MiR-128 regulation of glucose metabolism and cell proliferation in triple-negative breast cancer.
    Xiao M; Lou C; Xiao H; Yang Y; Cai X; Li C; Jia S; Huang Y
    Br J Surg; 2018 Jan; 105(1):75-85. PubMed ID: 29116653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-Dose Farnesyltransferase Inhibitor Suppresses HIF-1α and Snail Expression in Triple-Negative Breast Cancer MDA-MB-231 Cells In Vitro.
    Tanaka T; Ikegami Y; Nakazawa H; Kuriyama N; Oki M; Hanai J; Sukhatme VP; Kaneki M
    J Cell Physiol; 2017 Jan; 232(1):192-201. PubMed ID: 27137755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [HIF-1alpha expression and relationship involving tumor cell proliferation and angiogenesis in human breast carcinoma].
    Hao LS; Wang G; Qian K; Luo T; Li XJ; Wu XT
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jan; 38(1):60-3. PubMed ID: 17294729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIF-1α/Malat1/miR-141 Axis Activates Autophagy to Increase Proliferation, Migration, and Invasion in Triple-negative Breast Cancer.
    Xu F; Hu Y; Gao J; Wang J; Xie Y; Sun F; Wang L; Miyamoto A; Xia O; Zhang C
    Curr Cancer Drug Targets; 2023; 23(5):363-378. PubMed ID: 36579395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular biomarkers for prediction of response to treatment and survival in triple negative breast cancer patients from Egypt.
    Bahnassy A; Mohanad M; Ismail MF; Shaarawy S; El-Bastawisy A; Zekri AR
    Exp Mol Pathol; 2015 Oct; 99(2):303-11. PubMed ID: 26232605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ganoderic acid D attenuates gemcitabine resistance of triple-negative breast cancer cells by inhibiting glycolysis via HIF-1α destabilization.
    Luo B; Song L; Chen L; Cai Y; Zhang M; Wang S
    Phytomedicine; 2024 Jul; 129():155675. PubMed ID: 38678954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathological and prognostic significance of hypoxia-inducible factor-1 alpha in lung cancer: a systematic review with meta-analysis.
    Yang SL; Ren QG; Wen L; Hu JL
    J Huazhong Univ Sci Technolog Med Sci; 2016 Jun; 36(3):321-327. PubMed ID: 27376798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Co-expression of KIAA1199 and hypoxia-inducible factor 1α is a biomarker for an unfavorable prognosis in hepatocellular carcinoma.
    Wang D; Lu S; Zhang X; Huang L; Zhao H
    Medicine (Baltimore); 2020 Dec; 99(50):e23369. PubMed ID: 33327261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of hypoxia-inducible factor 1 alpha and its downstream targets in fibroepithelial tumors of the breast.
    Kuijper A; van der Groep P; van der Wall E; van Diest PJ
    Breast Cancer Res; 2005; 7(5):R808-18. PubMed ID: 16168127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Relationship of CXCR1, IκBα and HIF-1α Expression Levels with Clinicopathological Parameters in Colorectal Cancer.
    Sahami-Fard MH; Yazd EF; Khazaei Z
    Clin Lab; 2019 May; 65(5):. PubMed ID: 31115225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypoxia inducible factor 1alpha gene (HIF-1alpha) splice variants: potential prognostic biomarkers in breast cancer.
    Dales JP; Beaufils N; Silvy M; Picard C; Pauly V; Pradel V; Formisano-Tréziny C; Bonnier P; Giusiano S; Charpin C; Gabert J
    BMC Med; 2010 Jul; 8():44. PubMed ID: 20624301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oncogenic role of SIRT1 associated with tumor invasion, lymph node metastasis, and poor disease-free survival in triple negative breast cancer.
    Chung SY; Jung YY; Park IA; Kim H; Chung YR; Kim JY; Park SY; Im SA; Lee KH; Moon HG; Noh DY; Han W; Lee C; Kim TY; Ryu HS
    Clin Exp Metastasis; 2016 Feb; 33(2):179-85. PubMed ID: 26585892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Programmed Death Ligand 1 (PD-L1) Tumor Expression Is Associated with a Better Prognosis and Diabetic Disease in Triple Negative Breast Cancer Patients.
    Botti G; Collina F; Scognamiglio G; Rao F; Peluso V; De Cecio R; Piezzo M; Landi G; De Laurentiis M; Cantile M; Di Bonito M
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28230773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pilot Study on MAGE-C2 as a Potential Biomarker for Triple-Negative Breast Cancer.
    Zhao Q; Xu WT; Shalieer T
    Dis Markers; 2016; 2016():2325987. PubMed ID: 27843173
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.